References
- Michelsen KS, Arditi M. Toll-like receptors and innate immunity in gut homeostasis and pathology. Curr. Opin. Hematol.14, 48–54 (2007).
- Srikanth CV, McCormick BA, Interactions of the intestinal epithelium with the pathogen and the indigenous microbiota: a three-way crosstalk. Interdiscip. Perspect. Infect. Dis.27, 62–68 (2008).
- Iwasaki A. Mucosal dendritic cells. Annu. Rev. Immunol.25, 381–418 (2007).
- Weltzin R, Lucia-Jandris P, Michetti P et al. Binding and transepithelial transport of immunoglobulins by intestinal M cells: demonstration using monoclonal IgA antibodies against enteric viral proteins. J. Cell Biol.108, 1673–1685 (1989).
- Neutra MR, Kraehenbuhl JP. The role of transepithelial transport by M cells in microbial invasion and host defense. J. Cell Sci. Suppl.17, 209–215 (1993).
- Rimoldi M, Chieppa M, Salucci V et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol.6, 507–514 (2005).
- Turner JR. Intestinal mucosal barrier function in health and disease. Nat. Rev.9, 799–809 (2009).
- Wilson C, Ouellette A, Satchell D et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science286, 113–117 (1999).
- Ayabe T, Satchell D, Wilson C et al. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol.1, 113–118 (2000).
- Margolis KG, Stevanovic K, Karamooz N et al. Enteric neuronal density contributes to the severity of intestinal inflammation. Gastroenterology141, 588–598 (2011).
- Charagundla SR, Levine MS, Torigian DA et al. Diffuse intestinal ganglioneuromatosis mimicking Crohn’s disease. AJR Am. J. Roentgenol.182, 1166–1168 (2004).
- Steinman RM. Dendritic cells in vivo: a key target for a new vaccine science. Immunity29, 319–324 (2008).
- Huang FP, Platt N, Wykes M et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med.191, 435–444 (2000).
- Smith PD, Ochsenbauer-Jambor C, Smythies LE. Intestinal macrophages: unique effector cells of the innate immune system. Immunol. Rev.206, 149–159 (2005).
- Wendelsdorf K, Bassaganya-Riera J, Hontecillas R et al. Model of colonic inflammation: immune modulatory mechanisms in inflammatory bowel disease. J. Theo. Bio.4, 1225–1239 (2010).
- Eckburg PB, Bik EM, Bernstein CN et al. Diversity of the human intestinal microbial flora. Science308, 1635–1638 (2005).
- Sartor RB. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res. Immunol.148, 567–576 (1997).
- Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci. STKE357, 13 (2006).
- Beutler B, Hoebe K, Du X et al. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J. Leukoc. Biol.74, 479–485 (2003).
- Kumar A, Wu H, Collier-Hyams LS et al. Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J.26, 4457–4466 (2007).
- Kelly D, Cambell JI, King TP et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat. Immunol.5, 104–112 (2004).
- Silverman N, Paquette N, Immunology. The right resident bugs. Science319, 734–735 (2008).
- Neish AS, Gewirtz AT, Zeng H et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science289, 1560–1563 (2000).
- Stremmel W, Merle U, Zahn A et al. Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut54, 966–971 (2005).
- De Hertogh G, Aerssens J, De Hoogt R et al. Validation of 16S rDNA sequencing in microdissected bowel biopsies from Crohn’s disease patients to assess bacterial flora diversity. J. Pathol.209, 532–539 (2006).
- Sears CL. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin. Microbiol. Rev.22, 349–369 (2009).
- Sack RB, Myers LL, Almeido-Hill J et al. Enterotoxigenic Bacteroides fragilis: epidemiologic studies of its role as a human diarrhoeal pathogen. J. Diarrhoeal Dis. Res.10, 4–9 (1992).
- Prindiville TP, Sheikh RA, Cohen SH et al.Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg. Infect. Dis.6, 171–174 (2000).
- Toprak NU, Yagci A, Gulloglu BM et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin. Microbiol. Infect.12, 782–786 (2006).
- Wu S, Rhee KJ, Zhang M et al.Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage. J. Cell Sci.120, 1944–1952 (2007).
- Halle S, Bumann D, Herbrand H et al. Solitary intestinal lymphoid tissue provides a productive port of entry for Salmonella enterica serovar Typhimurium. Infect. Immun.75, 1577–1585 (2007).
- Niess JH, Brand S, Gu X et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science307, 254–258 (2005).
- Vazquez-Torres A, Jones-Carson J, Baumler AJ et al. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature401, 804–808 (1999).
- Klapproth JM, Sasaki M, Sherman M et al.Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo. Infect. Immun.73, 1441–1451 (2005).
- Guttman JA, Samki FN, Li Y et al. Evidence that tight junctions are disrupted due to intimate bacterial contact and not inflammation during attaching and effacing pathogen infection in vivo. Infect. Immun.74, 6075–6084 (2006).
- Satsangi J, Jewell DP, Bell JI. The genetics of inflammatory bowel disease. Gut40, 572–574 (1997).
- Rioux JD, Xavier RJ, Taylor KD et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet.39, 596–604 (2007).
- Hampe J, Franke A, Rosentiel P et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet.39, 207–211 (2007).
- Parkes M, Barrett JC, Prescott NJ et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn’s disease susceptibility. Nat. Genet.39, 830–832 (2007).
- Barrett JC, Hansoul S, Nicolae DL et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat. Genet.40, 955–962 (2008).
- Parham C, Chirica M, Timans J et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol.168, 5699–5708 (2002).
- Parrello T, Monteleone G, Cucchiara S et al. Up-regulation of the IL-12 receptor beta 2 chain in Crohn’s disease. J. Immunol.165, 7234–7239 (2000).
- Cua DJ, Sherlock J, Chen Y et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature421, 744–748 (2003).
- Saitoh T, Fujita N, Jang MH et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature456, 264–268 (2008).
- Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol.3, 521–533 (2003).
- Rahman MK, Midtling EH, Svingen PA et al. The pathogen recognition receptor NOD2 regulates human FOXP3+ T cell survival. J. Immunol.184, 7247–7256 (2010).
- Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science270, 1203–1207 (1995).
- Hue S, Ahern P, Buonocore S et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med.203, 2473–2483 (2006).
- Kullberg MC, Jankovic D, Feng CG et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med.203, 2485–2494 (2006).
- Uhlig HH, McKenzie BS, Hue S et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity25, 309–318 (2006).
- Yen D, Cheung J, Scheerens H et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest.116, 1310–1316 (2006).
- Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature448, 427–434 (2007).
- Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol.9, 641–649 (2008).
- Travassos LH, Carneiro LA, Ramjeet M et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol.11, 55–62 (2010).
- Galluzzi L, Kepp O, Zitvogel L et al. Bacterial invasion: linking autophagy and innate immunity. Curr. Biol.20, 106–108 (2010).
- Kuballa P, Huett A, Rioux JD et al. Impaired autophagy of an intracellular pathogen induced by a Crohn’s disease associated ATG16L1 variant. PLoS One3, 3391 (2008).
- Mizushima N, Levine B, Cuervo AM et al. Autophagy fights disease through cellular self-digestion. Nature451, 1069–1075 (2008).
- Thompson AI, Lees CW. Genetics of ulcerative colitis. Inflamm. Bowel Dis.17, 831–848 (2011).
- Chichlowski M, Hale LP. Bacterial–mucosal interactions in inflammatory bowel disease – an alliance gone bad. Am. J. Physiol. Gastrointest. Liver Physiol.295, 1139–1149 (2008)
- Heazlewood CK, Cook MC, Eri R et al. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med.5, 54 (2008).
- Hibi T, Ohara M, Kobayashi K et al. Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease. Gut35, 224–230 (1994).
- Folwaczny C, Noehl N, Tschop K et al. Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives. Gastroenterology113, 101–106 (1997).
- An G, Wei B, Xia B et al. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J. Exp. Med.204, 1417–1429 (2007).
- Ho SB, Dvorak LA, Moor RE et al. Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing. Gastroenterology131, 1501–1517 (2006).
- Van der Sluis M, De Koning BA, De Bruijn AC et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology131, 117–129 (2006).
- Madsen LK, Doyle JS, Jewell LD et al. Lactobacillus species prevents colitis in Interleukin-10 gene-deficient mice. Gastroenterology116(5), 1107–1114 (1999).
- Madsen LK, Cornish A, Soper P et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology121, 580 (2001).
- Clayburgh DR, Barrett TA, Tang Y et al. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J. Clin. Invest.115, 2702–2715 (2005).
- Zolotarevsky Y, Hecht G, Koutsouris A et al. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology123, 163–172 (2002).
- Su L, Shen L, Clayburgh DR et al. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology136, 551–563 (2009).
- Mahida YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflam. Bowel Dis.6, 21–33 (2000).
- Smythies LE, Sellers M, Clements RH et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest.115, 66–75 (2005).
- Iwasaki A, Kelsall BL. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer’s patch dendritic cells. J. Immunol.166, 4884–4890 (2001).
- Kuhn R, Lohler J, Rennick D et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell75, 263–274 (1993).
- Kamada N, Hisamatsu T, Okamoto S et al. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J. Immunol.175, 6900–6908 (2005).
- Imai Y, Irimura T. Quantitative measurement of carbohydrate binding activity of mouse macrophage lectin. J. Immunol. Methods171, 23–31 (1994).
- Yamamoto K, Ishida C, Shinohara Y et al. Interaction of immobilized recombinant mouse C-type macrophage lectin with glycopeptides and oligosaccharides. Biochemistry33, 8159–8166 (1994).
- Saba K, Denda-Nagai K, Irimura T. A C-type lectin MGL1/CD301a plays an anti-inflammatory role in murine experimental colitis. Am. J. Pathol.174, 144–152 (2009).
- Rugtveit J, Brandtzaeg P, Halstensen TS et al. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut35, 669–674 (1994).
- Meuret GA, Bitzi A, Hammer GB. Macrophage turnover in Crohn’s disease and ulcerative colitis. Gastroenterology74, 501–503 (1978).
- Grimm MC, Pullman WE, Bennett GM et al. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J. Gastrol. Hepatol.10, 387–395 (1995).
- Reinecker HC, Loh EY, Ringler DJ et al. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology108, 40–50 (1995).
- Liu K, Victora GD, Schwickert TA et al.In vivo analysis of dendritic cell development and homeostasis. Science324, 392–397 (2009).
- Schulz O, Jaensson E, Persson EK et al. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J. Exp. Med.206, 3101–3114 (2009).
- Krajina T, Leithauser F, Moller P et al. Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis. Eur. J. Immunol.33, 1073–1083 (2003).
- Duchmann R, Zeitz M. Treg suppress colitis: the role of TGF-β. Gut55, 604–606 (2006).
- Darrasse-Jeze G, Deroubaix S, Mouquet H et al. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med.206, 1853–1862 (2009).
- Siddiqui KR, Laffont S, Powrie F. E-cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis. Immunity32, 557–567 (2010).
- Jung S. Dendritic cells: a question of upbringing. Immunity32, 502–504 (2010).
- Varol C, Vallon-Eberhard A, Elinav E et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity31, 502–512 (2009).
- Hart AL, Al-Hassi HO, Rigby RJ et al. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology129, 50–65 (2005).
- de Baey A, Mende I, Baretton G et al. A subset of human dendritic cells in the T cell area of mucosa-associated lymphoid tissue with a high potential to produce TNF-alpha. J. Immunol.170, 5089–5094 (2003).
- de Baey A, Mende I, Riethmueller G et al. Phenotype and function of human dendritic cells derived from M-DC8(+) monocytes. Eur. J. Immunol.31, 1646–1655 (2001).
- Becker C, Wirtz S, Blessing M et al. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J. Clin. Invest.112, 693–706 (2003).
- Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science314, 1461–1463 (2006).
- Glas J, Seiderer J, Wetzke M et al. rs1004819 is the main disease-associated IL23R variant in German Crohn’s disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS One2, 819 (2007).
- Mizoguchi A, Ogawa A, Takedatsu H et al. Dependence of intestinal granuloma formation on unique myeloid DC-like cells. J. Clin. Invest.117, 605–615 (2007).
- von Boehmer H. Oral tolerance: is it all retinoic acid? J. Exp. Med.204, 1737–1739 (2007).
- Johansson-Lindbom B, Svensson M, Pabst O et al. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med.202, 1063–1073 (2005).
- Duerkop BA, Vaishnava S, Hooper LV. Immune responses to the microbiota at the intestinal mucosal surface. Immunity31, 368–376 (2009).
- Strober W. The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses. Immunity31, 377–388 (2009).
- Barnes MJ, Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity31, 401–411 (2009).
- Mosmann TR, Cherwinski H, Bond MW et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol.136, 2348–2357 (1986).
- Wilson NJ, Boniface K, Chan JR et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol.8, 950–957 (2007).
- Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol.170, 3939–3943 (2003).
- Maul J, Loddenkemper C, Mundt P et al. Peripheral and intestinal regulatory CD4+ CD25high T cells in inflammatory bowel disease. Gastroenterology128, 1868–1878 (2005).
- Makita S, Kanai T, Oshima S et al. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J. Immunol.173, 3119–3130 (2004).
- Defranco AL, Locksley RM, Robertson M. The immune response in infection and inflammatory disease. Immunity218–219 (2007).
- Bellizzi AM, Frankel WL. Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Adv. Anatom. Pathol.16, 405–417 (2009).
- Rogler G. Gastrointestinal and liver adverse effects of drugs used for treating IBD. Best Pract. Res. Clin. Gastroenterol.24, 157–165 (2010).
- Scribano M, Prantera C, Review article: medical treatment of moderate to severe Crohn’s disease. Aliment. Pharmacol. Ther.17, 23–30 (2003).
- Truelove SC, Witts LJ. Cortisone and corticotrophin in ulcerative colitis. BMJ1, 387–394 (1959).
- Jewell DP. Corticosteroids for the management of ulcerative colitis and Crohn’s disease. Gastroenterol. Clin. North Am.18, 21–34 (1989).
- Brattsand R, Linden M. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment. Pharmacol. Ther.10, 81–90 (1996).
- de Haij S, Daha MR, van Kooten C. Mechanism of steroid action in renal epithelial cells. Kidney Int.65, 1577–1588 (2004).
- Di Fazano CS, Messica O, Quennesson S et al. Two new cases of glucocorticoid-induced pancreatitis. Rev. Rhum. Engl. Ed.66, 235 (1999).
- Sandborn WJ. Azathioprine: state of the art in inflammatory bowel disease. Scand. J. Gastroenterol. Suppl.225, 92–99 (1998).
- Garcia-Lopez S, Gomollon-Garcia F, Perez-Gisbert J. Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review. Gastroenterol. Hepatol.28, 607–614 (2005).
- Essayan DM. Cyclic nucleotide phosphodiesterases. J. Allergy Clin. Immunol.108, 671–680 (2001).
- Marques LJ, Zheng L, Poulakis N et al. Pentoxifylline inhibits TNF-α production from human alveolar macrophages. Am. J. Respir. Crit. Care Med.159, 508–511 (1999).
- Brustolim D, Ribeiro-dos-Santos R, Kast RE et al. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int. Immunopharmacol.6, 903–907 (2006).
- Pache I, Rogler G, Felley C. TNF-α blockers in inflammatory bowel diseases: practical consensus recommendations and a user’s guide. Swiss. Med. Wkly139, 278–287 (2009).
- Mohamadzadeh M, Duong T, Hoover T et al. Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria. Expert Rev. Vac.7, 163–174 (2008).
- Dal Bello F, Hertel C. Oral cavity as natural reservoir for intestinal lactobacilli. Syst. Appl. Microbiol.29, 69–76 (2006).
- Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek82, 279–289 (2002).
- Roberts M, Chatfield S, Pickard D et al. Comparison of abilities of Salmonella enterica Serovar Typhimurium aroA aroD and aroA htrA mutants to act as live vectors. Infect. Immun.68, 6041–6043 (2000).
- Stevenson A, Roberts M. Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens. FEMS Immunol. Med. Microbiol.37, 121–128 (2003).
- Saklani-Jusforgues H, Fontan E, Soussi N et al. Enteral immunization with attenuated recombinant Listeria monocytogenes as a live vaccine vector: organ-dependent dynamics of CD4 T lymphocytes reactive to a Leishmania major tracer epitope. Infect. Immun.71, 1083–1090 (2003).
- Pouwels PH, Leer RJ, Shaw M et al. Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int. J. Food Microbiol.41, 155–167 (1998).
- Mercenier A, Pavan S, Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr. Pharm. Des.9, 175–191 (2003).
- Cain AM, Kelly Karpa KD. Clinical utility of probiotics in inflammatory bowel disease. Alt. Ther.17, 72–79 (2011).
- Fitzpatrick LR, Hertzog KL, Quatse AL et al. Effects of the probiotic formulation VSL#3 on colitis in weanling rats. J. Pediatr. Gastroenterol. Nutr.44, 561–570 (2007).
- Shibolet O, Karmeli F, Eliakim R et al. Variable response to probiotics in two models of experimental colitis in rats. Inflamm. Bowel Dis.8, 399–406 (2002).
- Chen ML, Yan BS, Bando Y et al. Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFbeta-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis. J. Immunol.180, 7327–7337 (2008).
- Lammers KM, Vergopoulos A, Babel N et al. Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. Inflamm. Bowel Dis.11, 447–454 (2005).
- Ulisse S, Gionchetti P, D’Alo S et al. Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am. J. Gastroenterol.96, 2691–2699 (2001).
- Di Giacinto C, Marnaro M, Sanchez M et al. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J. Immunol.174, 3237–3246 (2005).
- Bibiloni R, Fedorak RN, Tannock GW et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol.100, 1539–1546 (2005).
- Madsen K, Cornish A, Soper P et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology121, 580–591 (2001).
- Rachmilewitz D, Katakura K, Karmell F et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology126, 520–528 (2004).
- Pagnini C, Saeed R, Bamias G et al. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc. Natl Acad. Sci. USA107, 454–459 (2010).
- Shen B, Brezezinski A, Fazio VW et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment. Pharmacol. Ther.22, 721–728 (2005).
- Eizaguirre I, Urkia NG, Arsensio AB et al. Probiotic supplementation reduces the risk of bacterial translocation in experimental short bowel syndrome. J. Pediatr. Surg.37, 699–702 (2002).
- Mayer ML, Phillips CM, Stadnyk AW et al. Synergistic BM–DC activation and immune induction by the oral vaccine vector Streptococcus gordonii and exogenous tumor necrosis factor. Mol. Immunol.46, 1883–1891 (2009).
- Mayer ML, Phillips CM, Townsend RA et al. Differential activation of dendritic cells by Toll-like receptor agonists isolated from the Gram positive vaccine vector Streptococcus gordonii. Scand. J. Immunol.69, 351–356 (2009).
- Mohamadzadeh M, Pfeiler EA, Brown JB et al. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl Acad. Sci. USA108, 4623–4630 (2011).
Websites
- Paneth’s cell. www.britannica.com/EBchecked/topic/441200/Paneths-cell
- Nutrition in pediatrics: basic science, clinical applications. http://books.google.com/books?id=wSTISCdSIosC&pg=PA244&lpg=PA244&dq=paneth+cell&source=vrt&ots=KZ4tH-wh4s&sig=mMRz3PETnVY9URDkCDyjoIGkLM8&hl=en&ei=fOR-TeW2BInagQeSyoGgCA&sa=X&oi=book_result&ct=result&resnum=13&ved=0CHkQ6AEwDA#v=onepage&q=paneth%20cell&f=false
- VSL#3 A clear answer for symptom relief. www.vsl3.com
- Products with probiotics: commercial strains sold as probiotics. www.usprobiotics.org/products.asp#commercial
- Custom Probiotics Inc. Lactobacilli and Bifidobacteria. www.customprobiotics.com/about_probiotics.htm